The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structure of the human class I histocompatibility antigen, HLA-A2
Bjorkman, P. J., Saper, M. A., Samraoui, B., Bennett, W. S., Strominger, J. L., & Wiley, D. C. (1987) · Nature · doi:10.1038/329506a0 · Cited by 3,472
Townsend, A. (1986) · Cell · doi:10.1016/0092-8674(86)90019-x · Cited by 1,699
In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine
Deres, K., Schild, H., Wiesmüller, K.-H., Jung, G., & Rammensee, H.-G. (1989) · Nature · doi:10.1038/342561a0 · Cited by 631
Self-citationCellular peptide composition governed by major histocompatibility complex class I molecules
Falk, K., Rötzschke, O., & Rammensee, H.-G. (1990) · Nature · doi:10.1038/348248a0 · Cited by 431
Self-citationWraith, D. C., Smilek, D. E., Mitchell, D. J., Steinman, L., & McDevitt, H. O. (1989) · Cell · doi:10.1016/0092-8674(89)90287-0 · Cited by 389
Characterization of Naturally Occurring Minor Histocompatibility Peptides Including H-4 and H-Y
Rötzschke, O., Falk, K., Wallny, H.-J., Faath, S., & Rammensee, H.-G. (1990) · Science · doi:10.1126/science.1695760 · Cited by 214
Self-citationAntiviral cytotoxic T cell response induced by in vivo priming with a free synthetic peptide.
Aichele, P., Hengartner, H., Zinkernagel, R. M., & Schulz, M. (1990) · The Journal of experimental medicine · doi:10.1084/jem.171.5.1815 · Cited by 198
Bodmer, H. C., Pemberton, R. M., Rothbard, J. B., & Askonas, B. A. (1988) · Cell · doi:10.1016/0092-8674(88)90514-4 · Cited by 138
Selection of highly transfectable variant from mouse mastocytoma P815
Pel, A. V., Plaen, E. D., & Boon, T. (1985) · Somatic Cell and Molecular Genetics · doi:10.1007/bf01534840 · Cited by 131
Cited by
Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules
Falk, K., Rötzschke, O., Stevanovié, S., Jung, G., & Rammensee, H.-G. (1991) · Nature · doi:10.1038/351290a0 · Cited by 2,411
Self-citationHeterologous Protection Against Influenza by Injection of DNA Encoding a Viral Protein
Ulmer, J. B., Donnelly, J. J., Parker, S. E., Rhodes, G. H., Felgner, P. L., Dwarki, V. J., Gromkowski, S. H., Deck, R. R., DeWitt, C. M., Friedman, A., et al. (1993) · Science · doi:10.1126/science.8456302 · Cited by 2,318
MHC ligands and peptide motifs: first listing
Rammensee, H.-G., Friede, T., & Stevanović, S. (1995) · Immunogenetics · doi:10.1007/bf00172063 · Cited by 1,638
Self-citationCharacterization of Peptides Bound to the Class I MHC Molecule HLA-A2.1 by Mass Spectrometry
Hunt, D. F., Henderson, R. A., Shabanowitz, J., Sakaguchi, K., Michel, H., Sevilir, N., Cox, A. L., Appella, E., & Engelhard, V. H. (1992) · Science · doi:10.1126/science.1546328 · Cited by 1,198
Role of Bone Marrow-Derived Cells in Presenting MHC Class I-Restricted Tumor Antigens
Huang, A. Y. C., Golumbek, P., Ahmadzadeh, M., Jaffee, E., Pardoll, D., & Levitsky, H. (1994) · Science · doi:10.1126/science.7513904 · Cited by 1,160
Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy
Coulie, P. G., Van den Eynde, B. J., van der Bruggen, P., & Boon, T. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3670 · Cited by 1,138
Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 Å resolution
Saper, M. A., Bjorkman, P. J., & Wiley, D. C. (1991) · Journal of Molecular Biology · doi:10.1016/0022-2836(91)90567-p · Cited by 1,077
Sequence analysis of peptides bound to MHC class II molecules
Rudensky, A. Y., Preston-Hurlburt, P., Hong, S.-C., Barlow, A., & Janeway, C. A. (1991) · Nature · doi:10.1038/353622a0 · Cited by 1,075
A novel influenza A virus mitochondrial protein that induces cell death
Chen, W., Calvo, P. A., Malide, D., Gibbs, J., Schubert, U., Bacik, I., Basta, S., O'Neill, R., Schickli, J., Palese, P., et al. (2001) · Nature Medicine · doi:10.1038/nm1201-1306 · Cited by 1,040
The Biochemistry and Cell Biology of Antigen Processing and Presentation
Germain, R. (1993) · Annual Review of Immunology · doi:10.1146/annurev.immunol.11.1.403 · Cited by 1,020
Identification of self peptides bound to purified HLA-B27
Jardetzky, T. S., Lane, W. S., Robinson, R. A., Madden, D. R., & Wiley, D. C. (1991) · Nature · doi:10.1038/353326a0 · Cited by 827
Assembly, Transport, and Function of MHC Class II Molecules
Cresswell, P. (1994) · Annual Review of Immunology · doi:10.1146/annurev.immunol.12.1.259 · Cited by 807
Peptides Naturally Presented by MHC Class I Molecules
Rammensee, H. G., Falk, K., & Rötzschke, O. (1993) · Annual Review of Immunology · doi:10.1146/annurev.iy.11.040193.001241 · Cited by 799
Self-citationChicz, R. M., Urban, R. G., Lane, W. S., Gorga, J. C., Stern, L. J., Vignali, D. A. A., & Strominger, J. L. (1992) · Nature · doi:10.1038/358764a0 · Cited by 768
Peptide-binding specificity of the molecular chaperone BiP
Flynn, G. C., Pohl, J., Flocco, M. T., & Rothman, J. E. (1991) · Nature · doi:10.1038/353726a0 · Cited by 765
Emerging Principles for the Recognition of Peptide Antigens by MHC Class I Molecules
Matsumura, M., Fremont, D. H., Peterson, P. A., & Wilson, L. A. (1992) · Science · doi:10.1126/science.1323878 · Cited by 731
The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation
Madden, D. R., Gorga, J. C., Strominger, J. L., & Wiley, D. C. (1991) · Nature · doi:10.1038/353321a0 · Cited by 680
Traversari, C., van der Bruggen, P., Luescher, I. F., Lurquin, C., Chomez, P., Van Pel, A., De Plaen, E., Amar-Costesec, A., & Boon, T. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.5.1453 · Cited by 679
Zinkernagel, R. M. (1996) · Science · doi:10.1126/science.271.5246.173 · Cited by 651
Lebrón, J. A., Bennett, M. J., Vaughn, D. E., Chirino, A. J., Snow, P. M., Mintier, G. A., Feder, J. N., & Bjorkman, P. J. (1998) · Cell · doi:10.1016/s0092-8674(00)81151-4 · Cited by 638
Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules
Ruppert, J., Sidney, J., Celis, E., Kubo, R. T., Grey, H. M., & Sette, A. (1993) · Cell · doi:10.1016/0092-8674(93)90472-3 · Cited by 628
Identification of human cancers deficient in antigen processing.
Restifo, N. P., Esquivel, F., Kawakami, Y., Yewdell, J. W., Mulé, J. J., Rosenberg, S. A., & Bennink, J. R. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.2.265 · Cited by 624
Heat shock proteins transfer peptides during antigen processing and CTL priming
Srivastava, P., Udono, H., Blachere, N., & Li, Z. (1994) · Immunogenetics · doi:10.1007/bf00188611 · Cited by 569
Raz, E., Carson, D. A., Parker, S. E., Parr, T. B., Abai, A. M., Aichinger, G., Gromkowski, S. H., Singh, M., Lew, D., & Yankauckas, M. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.20.9519 · Cited by 543
MHC Class I Expression in Mice Lacking the Proteasome Subunit LMP-7
Fehling, H. J., Swat, W., Laplace, C., Kühn, R., Rajewsky, K., Müller, U., & von Boehmer, H. (1994) · Science · doi:10.1126/science.8066463 · Cited by 525
HLA-A2.1-Associated Peptides from a Mutant Cell Line: A Second Pathway of Antigen Presentation
Henderson, R. A., Michel, H., Sakaguchi, K., Shabanowitz, J., Appella, E., Hunt, D. F., & Engelhard, V. H. (1992) · Science · doi:10.1126/science.1546329 · Cited by 520
Exact prediction of a natural T cell epitope
Rötzschke, O., Falk, K., Stevanovic, S., Jung, G., Walden, P., & Rammensee, H. (1991) · European Journal of Immunology · doi:10.1002/eji.1830211136 · Cited by 446
Self-citationGermain, R. N., & Stefanová, I. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.467 · Cited by 436
Cellular peptide composition governed by major histocompatibility complex class I molecules
Falk, K., Rötzschke, O., & Rammensee, H.-G. (1990) · Nature · doi:10.1038/348248a0 · Cited by 431
Self-citationKarttunen, J., Sanderson, S., & Shastri, N. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.13.6020 · Cited by 418
Precise prediction of a dominant class I MHC-restricted epitope of Listeria monocytogenes
Pamer, E. G., Harty, J. T., & Bevan, M. J. (1991) · Nature · doi:10.1038/353852a0 · Cited by 417
Different length peptides bind to HLA-Aw68 similarly at their ends but bulge out in the middle
Guo, H.-C., Jardetzky, T. S., Garrettt, T. P. J., Lane, W. S., Strominger, J. L., & Wiley, D. C. (1992) · Nature · doi:10.1038/360364a0 · Cited by 404
Structure of Peptides Associated with Class I and Class II MHC Molecules
Engelhard, V. H. (1994) · Annual Review of Immunology · doi:10.1146/annurev.immunol.12.1.181 · Cited by 395
Huang, A. Y., Gulden, P. H., Woods, A. S., Thomas, M. C., Tong, C. D., Wang, W., Engelhard, V. H., Pasternack, G., Cotter, R., Hunt, D., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9730 · Cited by 388
TAP1-dependent peptide translocation in vitro is ATP dependent and peptide selective
Shepherd, J. C., Schumacher, T. N. M., Ashton-Rickardt, P. G., Imaeda, S., Ploegh, H. L., Janeway, C. A., & Tonegawa, S. (1993) · Cell · doi:10.1016/0092-8674(93)80058-m · Cited by 368
Penna, A., Chisari, F. V., Bertoletti, A., Missale, G., Fowler, P., Giuberti, T., Fiaccadori, F., & Ferrari, C. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.6.1565 · Cited by 365
Yewdell, J. W., & Bennink, J. R. (1992) · Advances in Immunology · doi:10.1016/s0065-2776(08)60875-5 · Cited by 361
Eradication of Established Tumors by CD8+ T Cell Adoptive Immunotherapy
Hanson, H. L., Donermeyer, D. L., Ikeda, H., White, J. M., Shankaran, V., Old, L. J., Shiku, H., Schreiber, R. D., & Allen, P. M. (2000) · Immunity · doi:10.1016/s1074-7613(00)00026-1 · Cited by 358
Mass spectrometry–based identification of MHC-bound peptides for immunopeptidomics
Purcell, A. W., Ramarathinam, S. H., & Ternette, N. (2019) · Nature Protocols · doi:10.1038/s41596-019-0133-y · Cited by 354
A role for the proteasome regulator PA28α in antigen presentation
Groettrup, M., Soza, A., Eggers, M., Kuehn, L., Dick, T. P., Schild, H., Rammensee, H.-G., Koszinowski, U. H., & Kloetzel, P.-M. (1996) · Nature · doi:10.1038/381166a0 · Cited by 337
Self-citationPeptide binding to class I MHC on living cells and quantitation of complexes required for CTL lysis
Christinck, E. R., Luscher, M. A., Barber, B. H., & Williams, D. B. (1991) · Nature · doi:10.1038/352067a0 · Cited by 332
Antigen presentation in cancer — mechanisms and clinical implications for immunotherapy
Yang, K., Halima, A., & Chan, T. A. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00789-4 · Cited by 321
Casanova, J. L., Romero, P., Widmann, C., Kourilsky, P., & Maryanski, J. L. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.6.1371 · Cited by 315
Producing Nature’s Gene-Chips: The Generation of Peptides for Display by MHC Class I Molecules
Shastri, N., Schwab, S., & Serwold, T. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064819 · Cited by 305
Targeting p53 as a general tumor antigen.
Theobald, M., Biggs, J., Dittmer, D., Levine, A. J., & Sherman, L. A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.26.11993 · Cited by 304
Pertmer, T. M., Roberts, T. R., & Haynes, J. R. (1996) · Journal of Virology · doi:10.1128/jvi.70.9.6119-6125.1996 · Cited by 303
Bertoletti, A., Ferrari, C., Fiaccadori, F., Penna, A., Margolskee, R., Schlicht, H. J., Fowler, P., Guilhot, S., & Chisari, F. V. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10445 · Cited by 301
Multiple Peptide Synthesis Methods and Their Applications. New Synthetic Methods (87)
Jung, G., & Beck‐Sickinger, A. G. (1992) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199203673 · Cited by 292
Self-citationKoziel, M. J., Dudley, D., Afdhal, N., Choo, Q. L., Houghton, M., Ralston, R., & Walker, B. D. (1993) · Journal of Virology · doi:10.1128/jvi.67.12.7522-7532.1993 · Cited by 287
Type I IFN Modulates Innate and Specific Antiviral Immunity
Durbin, J. E., Fernandez-Sesma, A., Lee, C.-K., Rao, T. D., Frey, A. B., Moran, T. M., Vukmanovic, S., García-Sastre, A., & Levy, D. E. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.8.4220 · Cited by 286
Li, Z., & Srivastava, P. K. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05983.x · Cited by 285
Ham-2 corrects the class I antigen-processing defect in RMA-S cells
Attaya, M., Jameson, S., Martinez, C. K., Hermel, E., Aldrich, C., Forman, J., Lindahl, K. F., Bevan, M. J., & Monaco, J. J. (1992) · Nature · doi:10.1038/355647a0 · Cited by 285
Moss, P. A., Moots, R. J., Rosenberg, W. M., Rowland-Jones, S. J., Bodmer, H. C., McMichael, A. J., & Bell, J. I. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.20.8987 · Cited by 282
Delivery of Epitopes by the Salmonella Type III Secretion System for Vaccine Development
Rüssmann, H., Shams, H., Poblete, F., Fu, Y., Galán, J. E., & Donis, R. O. (1998) · Science · doi:10.1126/science.281.5376.565 · Cited by 276
Tumor Eradication by Adoptive Transfer of Cytototic T Lymphocytes
(1992) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60294-8 · Cited by 275
Udaka, K., Tsomides, T. J., & Eisen, H. N. (1992) · Cell · doi:10.1016/0092-8674(92)90617-l · Cited by 274
Peters, B., Nielsen, M., & Sette, A. (2020) · Annual Review of Immunology · doi:10.1146/annurev-immunol-082119-124838 · Cited by 270
Falk, K., Rötzschke, O., Deres, K., Metzger, J., Jung, G., & Rammensee, H. G. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.2.425 · Cited by 266
Self-citationDick, T. P., Nussbaum, A. K., Deeg, M., Heinemeyer, W., Groll, M., Schirle, M., Keilholz, W., Stevanović, S., Wolf, D. H., Huber, R., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.40.25637 · Cited by 260
Self-citationGallimore, A. (1998) · Journal of Experimental Medicine · doi:10.1084/jem.187.10.1647 · Cited by 259
Profiling humoral immune responses to P. falciparum infection with protein microarrays
Doolan, D. L., Mu, Y., Unal, B., Sundaresh, S., Hirst, S., Valdez, C., Randall, A., Molina, D., Liang, X., Freilich, D. A., et al. (2008) · PROTEOMICS · doi:10.1002/pmic.200800194 · Cited by 257
CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma
Mandelboim, O., Berke, G., Fridkin, M., Feldman, M., Eisenstein, M., & Eisenbach, L. (1994) · Nature · doi:10.1038/369067a0 · Cited by 254
Enhancing immune responses using suicidal DNA vaccines
Berglund, P., Smerdou, C., Fleeton, M. N., Tubulekas, L., & Liljeström, P. (1998) · Nature Biotechnology · doi:10.1038/nbt0698-562 · Cited by 229
Self-replicating Semliki Forest virus RNA as recombinant vaccine
Zhou, X., Berglund, P., Rhodes, G., Parker, S. E., Jondal, M., & Liljeström, P. (1994) · Vaccine · doi:10.1016/0264-410x(94)90074-4 · Cited by 193
Zhou, X., Berglund, P., Zhao, H., Liljeström, P., & Jondal, M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.3009 · Cited by 115
Raghavan, M., Gastinel, L. N., & Bjorkman, P. J. (1993) · Biochemistry · doi:10.1021/bi00084a037 · Cited by 108
Definition and transfer of a serological epitope specific for peptide-empty forms of MHC class I
Yu, Y. Y. L., Myers, N. B., Hilbert, C. M., Harris, M. R., Balendiran, G. K., & Hansen, T. H. (1999) · International Immunology · doi:10.1093/intimm/11.12.1897 · Cited by 56
Marschütz, M. K., Zauner, W., Mattner, F., Otava, A., Buschle, M., & Bernkop-Schnürch, A. (2002) · Peptides · doi:10.1016/s0196-9781(02)00148-1 · Cited by 24
Facts and Hopes in Immunotherapy Strategies Targeting Antigens Derived from KRAS Mutations
Linette, G. P., Bear, A. S., & Carreno, B. M. (2024) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-1212 · Cited by 14
Metadata
- Authors
- Rötzschke, O., Falk, K., Deres, K., Schild, H., Norda, M., Metzger, J., Jung, G., & Rammensee, H.-G.
- Venue
- Nature
- Published
- 1990-11
- Volume
- 348
- Issue
- 6298
- Pages
- 252-254
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2063841466
- Cited by
- 769
- References
- 9
- FWCI
- 33.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.